Suvoda Vendor Qualification Assessment (VQA) Report and RFI CredentialsReport and RFI Access Request Form
Diligent Pharma has conducted an audit of Suvoda’s IRT, eConsent and eCOA solutions in accordance with industry best practices aligned to the WCG Avoca Quality Consortium (AQC) standards for clinical trial conduct.
Diligent is providing Suvoda’s current and prospective clients the opportunity to quickly acquire Suvoda’s qualification credentials. As part of this arrangement, trial sponsors can access the Vendor Qualification Assessment (VQA) report from our audit of Suvoda’s capabilities for a reduced fee.
This comprehensive report is available immediately through Diligent at a cost of 4,000 USD. This is being offered to Suvoda’s clients for a limited time only, through May 31, 2023. Additionally, Suvoda clients can gain access to Suvoda’s completed Request for Information (RFI) documents (also known as vendor qualification questionnaire data) at no additional cost.
1. Complete the form below. No payment is needed at this stage.
2. Your request will be approved by Suvoda. On approval you will be emailed a secure link to purchase the VQA report and RFI documents, and download a pdf copy of your invoice.
Diligent Client Support:
Manager, Provider Services
Diligent Pharma, LLC
179 Nassau Street, Suite 3A,
Princeton, NJ 08542
E: email@example.com (email preferred)
T: +1 484 645 1061
Accelerate your trials now